Integrated cardiovascular risk assessment: a balancing act between risk and benefits

被引：0
|
作者：
Hammond, Tim G. [1 ]
Valentin, Jean-Pierre [1 ]
机构：
[1] AstraZeneca, Global Safety Assessment, London, England
来源：
TOXICOLOGY LETTERS | 2013年 / 221卷
关键词：
D O I：
10.1016/j.toxlet.2013.06.084
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [21] Cardiovascular risk assessment
    Ferrieres, J.
    ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2012, 4 (04) : 248 - 258
  • [22] Assessment of Cardiovascular Risk
    Cooney, Marie Therese
    Cooney, Helen C.
    Dudina, Alexandra
    Graham, Ian M.
    CURRENT HYPERTENSION REPORTS, 2010, 12 (05) : 384 - 393
  • [23] Cardiovascular risk assessment
    Blom, D. J.
    SOUTH AFRICAN FAMILY PRACTICE, 2011, 53 (02) : 121 - 128
  • [24] Cardiovascular risk assessment
    Suarez, C.
    Alvarez-Sala, L.
    Mostaza, J.
    Asenjo, C.
    MEDICINA CLINICA, 2007, 129 (14): : 534 - 541
  • [25] Integrated enterprise balancing with integrated return and risk databases
    Faisst, U
    Buhl, HU
    WIRTSCHAFTSINFORMATIK, 2005, 47 (06): : 403 - +
  • [26] Cardiovascular Risk Assessment
    Pletcher, Mark J.
    Moran, Andrew E.
    MEDICAL CLINICS OF NORTH AMERICA, 2017, 101 (04) : 673 - +
  • [27] Assessment of Cardiovascular Risk
    Marie Therese Cooney
    Helen C. Cooney
    Alexandra Dudina
    Ian M. Graham
    Current Hypertension Reports, 2010, 12 : 384 - 393
  • [28] Integrated management of cardiovascular risk
    Cosentino, Eugenio Roberto
    Rinaldi, Elisa Rebecca
    Borghi, Claudio
    CLINICAL MANAGEMENT ISSUES, 2008, 2 (03) : 127 - 134
  • [29] An assessment of integrated risk assessment
    Vermeire, Theo
    Munns, Wayne R., Jr.
    Sekizawa, Jun
    Suter, Glenn
    Van der Kraak, Glen
    HUMAN AND ECOLOGICAL RISK ASSESSMENT, 2007, 13 (02): : 339 - 354
  • [30] No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost
    Lemaire, Vincent
    Hu, Chuanpu
    van der Graaf, Piet H.
    Chang, Steve
    Wang, Weirong
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (01) : 25 - 28
12345